NALTRIBEN MESYLATE structure
|
Common Name | NALTRIBEN MESYLATE | ||
---|---|---|---|---|
CAS Number | 111555-58-9 | Molecular Weight | 415.48 | |
Density | 1.5 g/cm3 | Boiling Point | 605.3ºC at 760 mmHg | |
Molecular Formula | C26H25NO4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 319.9ºC |
Use of NALTRIBEN MESYLATENaltriben is a selective δ2-opioid receptor antagonist and TRPM7 activator. Naltriben enhances glioblastoma cell migration and invasion. Naltriben can be used in research into neurological diseases and cancer[1][2]. |
Name | Naltriben |
---|---|
Synonym | More Synonyms |
Description | Naltriben is a selective δ2-opioid receptor antagonist and TRPM7 activator. Naltriben enhances glioblastoma cell migration and invasion. Naltriben can be used in research into neurological diseases and cancer[1][2]. |
---|---|
Related Catalog | |
References |
Density | 1.5 g/cm3 |
---|---|
Boiling Point | 605.3ºC at 760 mmHg |
Molecular Formula | C26H25NO4 |
Molecular Weight | 415.48 |
Flash Point | 319.9ºC |
Exact Mass | 511.16600 |
PSA | 128.82000 |
LogP | 4.36020 |
Vapour Pressure | 1.67E-15mmHg at 25°C |
Index of Refraction | 1.779 |
~81% NALTRIBEN MESYLATE CAS#:111555-58-9 |
Literature: Portoghese; Sultana; Nagase; Takemori Journal of Medicinal Chemistry, 1988 , vol. 31, # 2 p. 281 - 282 |
~% NALTRIBEN MESYLATE CAS#:111555-58-9 |
Literature: PROGENICS PHARMACEUTICALS, INC Patent: WO2009/67275 A1, 2009 ; Location in patent: Page/Page column 140-141 ; WO 2009/067275 A2 |
Precursor 3 | |
---|---|
DownStream 0 |
naltrindole benzofuran |
C26H25NO4 |
NTB |
HMS2089G18 |